Status:
COMPLETED
N-acetyl-cysteine (NAC) and Kidney Graft Function
Lead Sponsor:
Institut d'Anesthesiologie des Alpes Maritimes
Conditions:
Brain Death
Chronic Renal Insufficiency
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The goal of this study is to evaluate the effect of N-acetyl-cysteine (NAC) administration in organ donors on the kidney graft function of recipients.
Detailed Description
Ischemia-reperfusion is a major contributing factor for delayed renal function after transplantation. It has been shown that the administration of an antioxidant, i.e. NAC, in patients with chronic re...
Eligibility Criteria
Inclusion
- all recipient for kidney graft in our hospital
Exclusion
- transplantation out side our hospital
- refusal from the patient
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT00998972
Start Date
September 1 2006
End Date
June 1 2011
Last Update
July 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, Alpes Maritimes, France, 06000